Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis - Wikidata - wikimedia - TriplyDB

Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis

Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis

http://www.wikidata.org/entity/Q34466979

about

Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cells A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury Prioritizing functional modules mediating genetic perturbations and their phenotypic effects: a global strategy Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer.XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells.Correlation between expression of gastrin, somatostatin and cell apoptosis regulation gene bcl-2/bax in large intestine carcinoma.Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.The effect of co-administration of Lawsonia inermis extract and octreotide on experimental hepatocellular carcinoma A switch of G protein-coupled receptor binding preference from phosphoinositide 3-kinase (PI3K)-p85 to filamin A negatively controls the PI3K pathway.Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway.Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis Correlation between the expressions of gastrin, somatostatin and cyclin and cyclin-depend kinase in colorectal cancer.Peptide receptor targeting in cancer: the somatostatin paradigm.Gastrin - active participant or bystander in gastric carcinogenesis?Involvement of somatostatin receptor subtypes in membrane ion channel modification by somatostatin in pituitary somatotropes.Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment.Relationship between expression of gastrin, somatostatin, Fas/FasL and caspases in large intestinal carcinoma.Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells.Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2.Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.Effect of octreotide on human pancreatic cancer cells after transfected with somatostatin receptor type 2 gene.Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma.Antineoplastic effects of octreotide on human gallbladder cancer cells in vitro.Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand.Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells.3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: preferential expression of somatostatin receptor subtype 3.Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature Intergenomic consensus in multifactorial inheritance loci: the case of multiple sclerosis

P2860

Q24300160-ED00E8F7-46CE-449F-BBDE-99DB31F3CB75 Q24812181-E0E579B6-63A9-4106-880A-C1DEE0214850 Q28475948-8515A8F3-704E-4AD8-89A6-8EE637CC5587 Q30486113-0E614447-8F81-474B-A97D-1C4673F837E0 Q33867261-069053AA-4F29-4F3C-9A30-07F0498F40DB Q34091373-977BC125-A6E5-4704-A752-DDED4E5A2B1F Q34448027-7DA45F45-CA12-4D7A-8335-2353FD6185D5 Q34605456-FED60A0C-758A-4524-A545-CFE3B0B45DDC Q35216414-324CEE31-1D86-4C9D-AA18-0A55E911DEF6 Q35399221-C13F0628-0D02-4F9C-B275-829D26CEF55F Q35614440-8D2E2D19-BF1E-4658-B242-49F57A4B5FB3 Q35807246-0053C0F4-202F-4CF4-A101-A10CD9C30407 Q36309149-1C03EA9C-EAC1-4724-9FFC-373E7306B2D5 Q36474555-8CD21731-6503-4E4D-94BE-2AA06B979C02 Q36496793-9DCD1021-9925-4F97-A235-FA35CFF3BDD3 Q36638046-6F8A6D38-6390-4AB8-A4BF-DCB09EDC8F57 Q36664970-ACEE1C9C-82CE-4375-A3B1-F8CC53500AEE Q36950543-BDF46012-0E9F-4FF5-8D75-56199B313604 Q37211764-A137798C-BA96-4750-891B-4D21D509A0F1 Q37261898-35237453-6950-4EC3-B890-486DE746E4AD Q37394454-0FE4E483-B85D-40D7-9096-8C2FBE752C7F Q37483944-0DD3F691-7365-44A1-B24A-1DCE4BA6A605 Q37898112-BF494AB8-A4F1-462F-8171-487B10121448 Q38441413-ACF5E325-7E95-46C9-B501-26C9F1D66E07 Q39378866-85B74525-86B8-43C5-8A8F-7A4922D08AED Q39551743-897B5E98-2D08-4EF1-BF6A-6C67F17805CC Q39842258-777ED373-7355-4FA8-9484-E77F66C12083 Q40165727-EFAEFE0E-A0EF-4F3A-A076-7F44146E1981 Q40228737-4F9F065A-74C2-48D9-8E74-4F3A6F9CA644 Q40534198-C7CE0E46-8A84-4D6C-9E7B-3C52C2F3263C Q40537154-C44E3828-B647-4A50-8824-BAFF187275BA Q40571857-B36F3C99-A609-4951-BF1B-BB494C4F01E8 Q40603990-442C99A8-2A3A-441C-BAC2-5768BE728F7E Q42573914-F87DEC66-CFD4-487D-8023-4469F43DA135 Q46558903-1902B58D-74CF-4E49-A817-4D107FC5EC5C Q48364648-F5AC15DF-B87F-474D-B27C-1A10E9DCBD52 Q52560203-6A429EDA-CF1C-4948-AC9E-E4CF9AC9300A Q57144951-595342E8-78DD-484D-9FED-59E3138EB680 Q57836508-013AB331-37CB-46A9-A2C4-F1BDC7631572

P2860

Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis

http://www.wikidata.org/entity/Q34466979

description

2002 nî lūn-bûn

@nan

2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@ast

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@en

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@nl

type

label

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@ast

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@en

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@nl

prefLabel

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@ast

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@en

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@nl

P1433

Q34466979-948E0BDF-06AE-4355-9765-9AB4A00F41D9

P1476

Q34466979-70BBD2AF-7011-493C-8166-324C72B6B13B

P2093

Q34466979-16573C0C-AA19-4AF5-9840-16B01EB4B5AE

Q34466979-34A26D53-A846-445A-9FAF-E6DE743EA3BF

Q34466979-440FF48F-2D6C-4D04-86FA-84C5692C64E0

Q34466979-446D76E0-77AE-46C7-8901-E22EF36CA6F5

Q34466979-5995D9F3-7053-47CD-A510-CDA5FE245E6E

Q34466979-5F8DB46D-902D-4FF0-9D0B-4CCB3E9A50EA

Q34466979-95A870B4-CC62-48D9-9FE6-B2FB3492583C

Q34466979-B5827F27-DDF6-4F70-865A-A944A8C50250

Q34466979-F23BBE65-165A-40BA-9D50-77A86A21ECE6

P2860

Q34466979-01F661EB-7F57-412D-AA75-A4558B0C6C9B

Q34466979-0C2E58AD-3DCD-4AE3-A342-6D39249D597B

Q34466979-1633BEDD-5064-4B3A-B1CF-03BDBB1F315F

Q34466979-1CD43F40-6FA4-4799-8AE5-C22BBDB7C1FF

Q34466979-2B48AECE-F375-413A-8B34-61AE91840739

Q34466979-31E2ED44-7241-4DD0-A1BF-D7E3CF5936AB

Q34466979-33AF6350-2567-430F-A7B9-2FC14F0A6BE3

Q34466979-3C3EC489-44CA-4943-98C1-42F97DB1FA82

Q34466979-58EC9986-C4D9-4CDE-B6D9-46766A8D207F

Q34466979-5DC2682D-C89E-41B3-AC37-DBE058592638

P304

Q34466979-8E8114EF-1DA7-4FDE-81C8-FF13B9406B30

P31

Q34466979-023AFC2A-10FC-4F68-96AC-57321B4948A6

P356

Q34466979-102DD918-D01F-4E53-A4B4-F8AE0F4421B1

P407

Q34466979-76E63BCD-3EBF-4B8C-9094-7E109BFD7954

P433

Q34466979-F0E2A584-7605-47B7-9CA1-AB388DC9DE80

P478

Q34466979-806B4515-DBA5-4AFC-A07A-9A51012E334B

P50

Q34466979-5D2F0F0D-179E-4E2B-8CD1-0ADD90363362

P577

Q34466979-5CB65685-F3B3-40A8-A0CF-9B220B5540CB

P5875

Q34466979-E8F8BFA8-A515-4642-ADB1-063D3400EEB3

P698

Q34466979-11062C7E-FA92-4CEB-B533-30441D77A1DC

P932

Q34466979-E8C34744-F8A0-48FE-98B5-FAB3CC4A94E0

P356

PNAS.0136771100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Somatostatin receptor subtype ...... death ligand-induced apoptosis

@en

P2093

Christiane Susini

http://www.w3.org/2001/XMLSchema#string

Corinne Bousquet

http://www.w3.org/2001/XMLSchema#string

Julie Guillermet

http://www.w3.org/2001/XMLSchema#string

Louis Buscail

http://www.w3.org/2001/XMLSchema#string

Lucien Pradayrol

http://www.w3.org/2001/XMLSchema#string

Nathalie Saint-Laurent

http://www.w3.org/2001/XMLSchema#string

Olivier Cuvillier

http://www.w3.org/2001/XMLSchema#string

Philippe Rochaix

http://www.w3.org/2001/XMLSchema#string

Thierry Levade

http://www.w3.org/2001/XMLSchema#string

P2860

Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3

Death and anti-death: tumour resistance to apoptosis

Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.

Molecular aspects of pancreatic cancer and future perspectives.

Antiproliferative effect of somatostatin and analogs.

Hypothalamic hormones and cancer.

The machinery of programmed cell death.

Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells

Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.

Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.

P304

155-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0136771100

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10982900

http://www.w3.org/2001/XMLSchema#string

P698

12490654

http://www.w3.org/2001/XMLSchema#string

P932

140912

http://www.w3.org/2001/XMLSchema#string